StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Hey 2 mil on the OTC bid at 0.04 us

<< Previous

Bullboard Posts

Next >>

Post by Jonnyboy85on Oct 09, 2024 2:13pm

48 Views

Post# 36259731

Hey 2 mil on the OTC bid at 0.04 us

You gotta pump those numbers up, those are rookie numbers, running out of time before the tsx volumes are back and those asks arent having any of it lol shoulda bought when you had the chance;)

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3